TG Therapeutics Inc (TGTX)
34.50
+3.36
(+10.77%)
USD |
NASDAQ |
Nov 21, 16:00
34.60
+0.10
(+0.28%)
After-Hours: 20:00
TG Therapeutics Profit Margin (Quarterly): 4.63% for Sept. 30, 2024
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 4.63% |
| June 30, 2024 | 9.36% |
| March 31, 2024 | -16.87% |
| December 31, 2023 | -32.79% |
| September 30, 2023 | 68.71% |
| June 30, 2023 | -296.2% |
| March 31, 2023 | -502.8% |
| December 31, 2022 | -66.24K% |
| September 30, 2022 | -38.10K% |
| June 30, 2022 | -6.82K% |
| March 31, 2022 | -3.42K% |
| December 31, 2021 | -4.02K% |
| September 30, 2021 | -4.22K% |
| June 30, 2021 | -5.08K% |
| March 31, 2021 | -11.43K% |
| December 31, 2020 | -232.2K% |
| September 30, 2020 | -229.4K% |
| June 30, 2020 | -139.2K% |
| March 31, 2020 | -134.5K% |
| December 31, 2019 | -104.1K% |
| September 30, 2019 | -163.0K% |
| June 30, 2019 | -95.30K% |
| March 31, 2019 | -92.52K% |
| December 31, 2018 | -141.7K% |
| September 30, 2018 | -89.34K% |
| Date | Value |
|---|---|
| June 30, 2018 | -116.2K% |
| March 31, 2018 | -109.3K% |
| December 31, 2017 | -81.21K% |
| September 30, 2017 | -82.99K% |
| June 30, 2017 | -74.61K% |
| March 31, 2017 | -72.97K% |
| December 31, 2016 | -62.77K% |
| September 30, 2016 | -65.18K% |
| June 30, 2016 | -41.74K% |
| March 31, 2016 | -36.35K% |
| December 31, 2015 | -46.23K% |
| September 30, 2015 | -35.85K% |
| June 30, 2015 | -44.90K% |
| March 31, 2015 | -38.27K% |
| December 31, 2014 | -49.34K% |
| September 30, 2014 | -45.81K% |
| June 30, 2014 | -31.46K% |
| March 31, 2014 | -19.81K% |
| December 31, 2013 | -14.87K% |
| September 30, 2013 | -11.96K% |
| June 30, 2013 | -17.28K% |
| March 31, 2013 | -9.64K% |
| December 31, 2012 | -18.16K% |
| September 30, 2012 | |
| June 30, 2012 |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-232.2K%
Minimum
Dec 2020
68.71%
Maximum
Sep 2023
-48.97K%
Average
-4.65K%
Median
Profit Margin (Quarterly) Benchmarks
| ADMA Biologics Inc | 29.96% |
| Varex Imaging Corp | -24.31% |
| Rhythm Pharmaceuticals Inc | -131.2% |
| Inspire Medical Systems Inc | 9.10% |
| Mirum Pharmaceuticals Inc | -15.75% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -8.40% |
| Return on Assets | -3.55% |
| Return on Invested Capital | -4.78% |
| Gross Profit Margin (Quarterly) | 88.86% |
| Operating Margin (Quarterly) | 14.82% |
| Return on Net Operating Assets | -9.88% |